These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23915467)

  • 1. Organizational performance, Marketing strategy, and Financial strategic alignment: an empirical study on Iranian pharmaceutical firms.
    Mohammadzadeh M; Aarabi SM; Salamzadeh J
    Daru; 2013 Aug; 21(1):65. PubMed ID: 23915467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data of the impact of Aligning Business, IT, and Marketing Strategies on Firm Performance.
    Al-Surmi A; Cao G; Duan Y
    Data Brief; 2019 Dec; 27():104656. PubMed ID: 31687453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intellectual Capital and Financial Performance: Comparison With Financial and Pharmaceutical Industries in Vietnam.
    Zhang XB; Duc TP; Burgos Mutuc E; Tsai FS
    Front Psychol; 2021; 12():595615. PubMed ID: 33841234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does chief executive compensation predict financial performance or inaccurate financial reporting in listed companies: A systematic review.
    Rousseau D; Kim BJ; Splenda R; Young S; Lee J; Beck D
    Campbell Syst Rev; 2023 Dec; 19(4):e1370. PubMed ID: 38089569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of voluntary disclosure on financial performance: Empirical study on manufacturing industry in Indonesia.
    Meiryani ; Huang SM; Soepriyanto G; Jessica ; Fahlevi M; Grabowska S; Aljuaid M
    PLoS One; 2023; 18(6):e0285720. PubMed ID: 37267373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies.
    López-Toro AA; Sánchez-Teba EM; Benítez-Márquez MD; Rodríguez-Fernández M
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33923122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nexus between capital structure, firm-specific factors, macroeconomic factors and financial performance in the textile sector of Pakistan.
    Ullah A; Pinglu C; Ullah S; Zaman M; Hashmi SH
    Heliyon; 2020 Aug; 6(8):e04741. PubMed ID: 32895635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unpacking the importance of intangible skills in new product development and sustainable business performance; strategies for marketing managers.
    Ali S; Li G; Yang P; Hussain K; Latif Y
    PLoS One; 2020; 15(9):e0238743. PubMed ID: 32976509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects.
    Zhong Y; Wu X
    PLoS One; 2020; 15(3):e0229739. PubMed ID: 32134951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of capital structure on the profitability of pharmaceutical companies the case of iran.
    Mohammadzadeh M; Rahimi F; Rahimi F; Aarabi SM; Salamzadeh J
    Iran J Pharm Res; 2013; 12(3):573-7. PubMed ID: 24250664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adopting Occupational Health and Safety Management Standards: The Impact on Financial Performance in Pharmaceutical Firms in China.
    Yang M; Maresova P
    Risk Manag Healthc Policy; 2020; 13():1477-1487. PubMed ID: 32982506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and non-economic determinants of Iranian pharmaceutical companies' financial performance: an empirical study.
    Masoumi M; Ebadi Fard Azar F; RezaPour A; Mehrara M
    BMC Health Serv Res; 2019 Dec; 19(1):1011. PubMed ID: 31888627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An empirical study of supply chain sustainability with financial performances of Indian firms.
    Sachin N; Rajesh R
    Environ Dev Sustain; 2022; 24(5):6577-6601. PubMed ID: 34393619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does intangible assets affect the financial performance and policy of commercial banks' in the emerging market?
    Abebe Zelalem B; Ali Abebe A
    PLoS One; 2022; 17(8):e0272018. PubMed ID: 36006901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A business model predicting the impact of live-stream marketing on firms' stock price - An event study.
    Luo S; Shyu ML; Silalahi ADK; Shih IT
    Heliyon; 2022 Dec; 8(12):e12522. PubMed ID: 36593856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which comes first: employee attitudes or organizational financial and market performance?
    Schneider B; Hanges PJ; Smith DB; Salvaggio AN
    J Appl Psychol; 2003 Oct; 88(5):836-51. PubMed ID: 14516248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial aspects and the future of the pharmaceutical industry in the United States of america.
    Karamehic J; Ridic O; Ridic G; Jukic T; Coric J; Subasic D; Panjeta M; Saban A; Zunic L; Masic I
    Mater Sociomed; 2013 Dec; 25(4):286-90. PubMed ID: 24511277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.